Rapidly progressing giant invasive prolactinoma

Journal of Laryngology and Otology

Volumn 126, Issue 8, 2012, Pages 840-843

  Care, R H ^a   Sunkaraneni, V S ^b   Theaker, J ^c   Harries, P G ^c  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diagnosis; Nasopharynx; Prolactinoma; Radiology; Sinusitis

Indexed keywords

ADULT; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; NASOPHARYNX TUMOR; PROLACTINOMA; RARE DISEASE; REVIEW; SINUSITIS; SYMPTOMATOLOGY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PITUITARY NEOPLASMS; PROLACTINOMA; SINUSITIS;

EID: 84864072661     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215112001296     Document Type: Review

References (8)

1. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in thetreatment of prolactinomas. Endocr Rev 2006;27:485-534
2. Murphy FY, Vesely DL, Jordan RM, Flanigan S, Kohler PO. Giant invasive prolactinomas. Am J Med 1987;83:995-1002
3. Colao A, Sarno AD, Cappabianca P, Briganti F, Pivonello R, Somma CD et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol 2003;148:325-31
4. Minniti G, Jaffrain-Rea ML, Santoro A, Esposito V, Ferrante L, Delfini R et al. Giant prolactinomas presenting as skull base tumors. Surg Neurol 2002;57:99-103
5. Dafer RM, Jay WM. Headache and the eye. Curr Opin Ophthalmol 2009;20:520-4
6. Ciccarelli E, Camanni F. Diagnosis and drug therapy of prolactinoma. Drugs 1996;51:954-65
7. Cho EH, Lee SA, Chung JY, Koh EH, Cho YH, Kim JH et al. Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma. J Korean Med Sci 2009;24:874-8
8. Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R et al. Operative treatment of prolactinomas: Indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 2008;158:11-18.